Hongbing Zhao - Search Results

Year	Number of Results
2008	1
2009	1
2011	2
2012	2
2013	1
2015	1
2017	1
2021	1
2022	2
2023	3
2024	1

1

CAR T-Cell therapy for the management of mantle cell lymphoma.

Huang Z, Chavda VP, Bezbaruah R, Dhamne H, Yang DH, Zhao HB. Huang Z, et al. Mol Cancer. 2023 Mar 31;22(1):67. doi: 10.1186/s12943-023-01755-5. Mol Cancer. 2023. PMID: 37004047 Free PMC article. Review.

2

Nivolumab and relatlimab for the treatment of melanoma.

Chen XY, Li YD, Xie Y, Cao LQ, Ashby CR Jr, Zhao H, Chen ZS. Chen XY, et al. Among authors: zhao h. Drugs Today (Barc). 2023 Feb;59(2):91-104. doi: 10.1358/dot.2023.59.2.3509756. Drugs Today (Barc). 2023. PMID: 36811409 Review.

3

An integrated flexible film as cathode for High-Performance Lithium-Sulfur battery.

Li Y, Ye D, Wang Y, Liu W, Guo R, Pei H, Zhao H, Zhao K, Xie J, Kong J, Zhang J. Li Y, et al. Among authors: zhao h. J Colloid Interface Sci. 2022 Jan 15;606(Pt 2):1627-1635. doi: 10.1016/j.jcis.2021.08.138. Epub 2021 Aug 24. J Colloid Interface Sci. 2022. PMID: 34500164

4

Enhanced external counterpulsation ameliorates endothelial dysfunction and elevates exercise tolerance in patients with coronary artery disease.

Yang H, Song L, Ning X, Ma Y, Xue A, Zhao H, Du Y, Lu Q, Liu Z, Wang J. Yang H, et al. Among authors: zhao h. Front Cardiovasc Med. 2022 Nov 29;9:997109. doi: 10.3389/fcvm.2022.997109. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36523357 Free PMC article.

5

YHHU0895, a novel synthetic small-molecule microtubule-destabilizing agent, effectively overcomes P-glycoprotein-mediated tumor multidrug resistance.

Zhao H, Quan H, Xie C, Xu Y, Xie F, Hu Y, Lou L. Zhao H, et al. Cancer Lett. 2012 Jan 1;314(1):54-62. doi: 10.1016/j.canlet.2011.09.013. Epub 2011 Sep 19. Cancer Lett. 2012. PMID: 21982683

6

Comparative efficacy of different Chinese patent medicines in preventing restenosis after percutaneous coronary intervention: a systematic review and Bayesian network meta-analysis of randomized clinical trials.

Fan J, Li T, Pu F, Guo N, Wang J, Gao Y, Zhao H, Wang X, Zhu H. Fan J, et al. Among authors: zhao h. Front Pharmacol. 2024 Jan 5;14:1265766. doi: 10.3389/fphar.2023.1265766. eCollection 2023. Front Pharmacol. 2024. PMID: 38249344 Free PMC article.

7

A novel and simple hollow-fiber assay for in vivo evaluation of nonpeptidyl thrombopoietin receptor agonists.

Xie CY, Xu YP, Zhao HB, Lou LG. Xie CY, et al. Exp Hematol. 2012 May;40(5):386-92. doi: 10.1016/j.exphem.2012.01.010. Epub 2012 Jan 21. Exp Hematol. 2012. PMID: 22269115 Free article.

8

Grb7 is over-expressed in cervical cancer and facilitate invasion and inhibit apoptosis in cervical cancer cells.

Zhao HB, Zhang XF, Jia XL, Wang HB. Zhao HB, et al. Pathol Res Pract. 2017 Sep;213(9):1180-1184. doi: 10.1016/j.prp.2017.05.013. Epub 2017 Jul 26. Pathol Res Pract. 2017. PMID: 28780081

9

Synthesis and biological evaluation of 2,4,5-substituted pyrimidines as a new class of tubulin polymerization inhibitors.

Xie F, Zhao H, Li D, Chen H, Quan H, Shi X, Lou L, Hu Y. Xie F, et al. Among authors: zhao h. J Med Chem. 2011 May 12;54(9):3200-5. doi: 10.1021/jm101388d. Epub 2011 Apr 11. J Med Chem. 2011. PMID: 21480626

10

Synthesis and biological evaluation of novel 2,4,5-substituted pyrimidine derivatives for anticancer activity.

Xie F, Zhao H, Zhao L, Lou L, Hu Y. Xie F, et al. Among authors: zhao h. Bioorg Med Chem Lett. 2009 Jan 1;19(1):275-8. doi: 10.1016/j.bmcl.2008.09.067. Epub 2008 Sep 21. Bioorg Med Chem Lett. 2009. PMID: 19028425

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

12 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year